CROX

Crocs, Inc.

$120.18

-2.40% 2026-10-19

Consumer DiscretionaryS&P 400

1M 3M 6M 1Y 2Y

CROXSPY

+2.8%

-1.7%

-11.2%

+8.1%

YTD

+40.5%

+44.8%

Grades vs sector

Momentum

93rd pct in sector

12-1 return: +43.6%
Percentile within its GICS sector across the S&P 1500.

Growth

42nd pct in sector

Revenue growth (YoY): +2.6%
Percentile within its GICS sector across the S&P 1500.

Value

83rd pct in sector

A-

Forward E/P: 12.2% · EBITDA/EV: 12.5%
Percentile within its GICS sector across the S&P 1500.

Profitability

84th pct in sector

A-

Profit margin: +14.6% · Return on equity: +42.3%
Percentile within its GICS sector across the S&P 1500.

Revisions

no data

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 3 live models right now.

Momentum Top 15

not ranked (outside this model's universe or screens)

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

Key stats

Market cap$5.8B

P/E (trailing)10.5

P/E (forward)8.0

52-week range73.21 – 141.28

Revenue growth (YoY, latest qtr)+2.6%

Dividend yield0.00%

Analyst consensusBuy (12)

Mean price target$138.75 (+15%)

Valuation & fundamentals

Bottom line

Looks undervalued

Model read-out from the numbers below, not advice. Score +4 (DCF counts double).

▲DCF (base case)above the price by 19%

▲Forward P/E vs sector8.0x vs median 13.4x

•Piotroski F-score5/9

▲Altman Z4.1 (safe)

▲Net debt / EBITDA1.2x

▲Analyst target+15% (12 analysts)

Discounted cash flow

Bear

$90

-25%

growth -2% · disc. 13.0% · term. 2.0%

Base

$143

+19%

growth 3% · disc. 12.0% · term. 2.5%

Bull

$204

+69%

growth 6% · disc. 11.0% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 1% a year for 10 years.

Implied

+1%/yr

FCF, last 3 yrs

+10%/yr

FCF, last 5 yrs

+24%/yr

Revenue, last 3 yrs

+4%/yr

Revenue, last 5 yrs

+24%/yr

Same inputs as the DCF above: trailing free cash flow 0.7B, 12.0% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.56 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Consumer Discretionary

P/E (trailing)

sector median 17.7× · 16th pct

10.5×
cheaper

Forward P/E

sector median 13.4× · 12th pct

8.0×
cheaper

EV / EBITDA

sector median 11.3× · 15th pct

7.5×
cheaper

Price / sales

sector median 1.2× · 55th pct

1.4×
pricier

Price / book

sector median 2.8× · 62nd pct

4.2×
pricier

FCF yield

sector median 6.6% · 82nd pct

12.2%
cheaper

Forward EPS $15.01 vs trailing $11.41 (+32% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

57.5%

Operating margin

20.7%

FCF margin

17.4%

Net margin

14.6%

Return on equity

42.9%

Return on invested capital

26.0%

Net debt / EBITDA

1.2×

Current ratio

1.5×

Interest cover

10.1×

Cash conversion (OCF/NI)

1.3×

Piotroski F-score 5/9 · last two fiscal years

✗ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✓ No share dilution✗ Gross margin improved✓ Asset turnover improved

Altman Z-score 4.1 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$139

+15%

Analysts

Buy

Range

$95–$163

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$4.0B	$-81.2M	$659.2M
2024	$4.1B	$950.1M	$923.1M
2023	$4.0B	$792.6M	$814.8M
2022	$3.6B	$540.2M	$499.0M
2021	$2.3B	$725.7M	$511.2M
2020	$1.4B	$312.9M	$224.9M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +4.4%.

Earnings

Next report: 2026-10-29 · before open · EPS est 3.31

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-07-30	4.35	4.55	+4.7%
2026-04-30	2.79	2.99	+7.2%
2026-02-12	1.91	2.29	+19.7%
2025-10-30	2.36	2.92	+23.7%
2025-08-07	4.02	4.23	+5.3%
2025-05-08	2.49	3.00	+20.6%
2025-02-13	2.26	2.52	+11.3%
2024-10-29	3.11	3.60	+15.9%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$1.2B	+2.6%
2026-03-31	$921.5M	–
2025-12-31	$957.6M	–
2025-09-30	$996.3M	–
2025-06-30	$1.1B	–

Analyst actions

Barclays

2026-10-15 · up

Equal-Weight → Overweight
PT $139

UBS

2026-07-31 · main

Neutral → Neutral
PT $120

Barclays

2026-07-31 · main

Equal-Weight → Equal-Weight
PT $118

B of A Securities

2026-07-23 · main

Buy → Buy
PT $160

Seaport Global

2026-07-20 · main

Buy → Buy
PT $160

Piper Sandler

2026-06-26 · up

Neutral → Overweight
PT $150

Insider trades

Smach Thomas J

Director · 2026-09-15

BUY
$75.8K

Kaplan Beth J

Director · 2026-09-15

BUY
$99.2K

Smach Thomas J

Director · 2026-09-10

BUY
$109.3K

Smach Thomas J

Director · 2026-09-10

BUY
$328.3K

Rees Andrew

Director, Chief Executive Officer · 2026-08-10

SELL
$1.3M

Rees Andrew

Director, Chief Executive Officer · 2026-08-10

SELL
$1.2M

Rees Andrew

Director, Chief Executive Officer · 2026-08-10

SELL
$112.0K

Rees Andrew

Director, Chief Executive Officer · 2026-08-07

SELL
$796.5K

Rees Andrew

Director, Chief Executive Officer · 2026-08-07

SELL
$580.0K

Rees Andrew

Director, Chief Executive Officer · 2026-08-07

SELL
$129.0K

None

None · None

SELL
–

None

None · None

SELL
–

News

Nike Stock Has Been Dismal. Why It’s Time to Be Bullish.

Barrons.com · Oct 17

Crocs (CROX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks · Oct 16

Is Analyst Upgrade Altering The Investment Case For Crocs Stock?

Simply Wall St. · Oct 16

Is Crocs (CROX) Getting Too Expensive After A 50% Run?

Simply Wall St. · Oct 16

Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure

Stocktwits · Oct 16

Why Crocs (CROX) Stock Is Up Today

StockStory · Oct 15

Crocs Shares Rise After Barclays Upgrade

MT Newswires · Oct 15

Barclays bullish on Crocs, sees multi-year growth story

Investing.com · Oct 15

Here Are Thursday’s Top Wall Street Analyst Research Calls: AngloGold Ashanti, Bank of America, Cirrus Logic, Crocs, Diamondback Energy, Devon Energy, Netflix, PayPal, Spotify Technolgy , and More

24/7 Wall St. · Oct 15

Stats refreshed 2026-10-19 19:01:53 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Hypothetical research for education, not investment advice. Data: Yahoo Finance (via yfinance, delayed), SEC EDGAR.

Disclaimer Terms Privacy Glossary Track record Data status